找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Immunotherapy; Aung Naing,Joud Hajjar Book 2021Latest edition The Editor(s) (if applicable) and The Author(s), under exclusive license to

[复制链接]
楼主: 选民
发表于 2025-3-27 00:10:54 | 显示全部楼层
发表于 2025-3-27 01:37:04 | 显示全部楼层
发表于 2025-3-27 08:20:42 | 显示全部楼层
发表于 2025-3-27 12:17:47 | 显示全部楼层
Skin Reactions to Immune Checkpoint Inhibitors,patients, 43.5% have a cutaneous AE, and, at our institution, 20% of them had a dose interruption as a result. This means potentially 9% of patients have dose interruption of ipilimumab because of their cutaneous AEs. In the following chapter, we review the categories of these drugs, common cutaneous effects, their grading, and management options.
发表于 2025-3-27 17:00:47 | 显示全部楼层
Immune-Related Oral, Otologic, and Ocular Adverse Events,onal chemotherapy are well known, the toxicity profile of emerging immune therapies is not fully elucidated. They have been associated with atypical side effects labeled collectively as immune-related adverse events (irAEs).
发表于 2025-3-27 17:56:08 | 显示全部楼层
发表于 2025-3-28 02:00:30 | 显示全部楼层
0065-2598 me the challenges associated with immunotherapy.Presents cut.The field of immuno-oncology continues to rapidly evolve as new insights to fight and treat cancer emerge. The fourth edition of .Immunotherapy. provides the most current overview of immuno-oncology in different cancer types and toxicities
发表于 2025-3-28 06:06:30 | 显示全部楼层
The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
发表于 2025-3-28 09:42:41 | 显示全部楼层
发表于 2025-3-28 10:45:02 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 21:55
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表